Tag: Food and Drug Administration
Proposed CBD Legislation Receives Criticism from Consumer Groups
WASHINGTON, D.C. – Introduced in the U.S. House of Representatives on February 4, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act...
Hemp Industry Members File Suit Over DEA Regulatory Overreach
WASHINGTON, D.C. – The Hemp Industry Association (HIA) and RE Botanicals, Inc. on Monday filed a complaint in federal court against the Drug Enforcement...
FDA Planning for Large-Scale CBD Product Testing
WASHINGTON, D.C. – The Food and Drug Administration (FDA) recently published a "contract opportunity" advertisement to the Federal government's beta website for "people who...
FDA Approves More Uses for Epidiolex
CARLSBAD, Calif. – Epidiolex, the first FDA-approved prescription medication containing a cannabis derivative, has received approval from the U.S. Food and Drug Administration for...
Is CBD on the Cusp of FDA Approval?
Don’t believe everything you read. Despite the widespread misinformation campaign that cannabidiol (CBD), which is believed to provide medical benefits, is fully legal, that...
FDA Releases Guidelines on Research Related to Cannabis-Derived Compounds
WASHINGTON, D.C. – The Food and Drug Administration (FDA) this week released draft guidelines for the creation of cannabis research regulations. The guidance titled...
DOT Cautions Commercial Drivers: CBD Products May Lead to Positive Drug Tests
WASHINGTON, D.C. – As the hemp industry matures, cannabidiol products such as oils and massage creams continue to gain mainstream success specifically because they...
How the CBD Industry Can Earn Trust While Awaiting FDA Regulation
Over the past several years, CBD has surpassed every emerging health trend to become the hottest thing since sliced bread. According to a recent...
Product Recall Issued for CBD Oil Due to Lead Contamination
WASHINGTON, D.C. – A batch of CBD oil has been voluntarily recalled by its manufacturer after testing positive for higher than acceptable levels of...
FDA Continues Public Comment Period on CBD ‘Indefinitely’
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) on Wednesday published a report in response to the U.S. Congress’ request for guidelines...
